In addition, evidence from a population-based study showed that individuals with post-pancreatitis diabetes mellitus are more likely to receive insulin therapy by 16.8% at five years after diabetes diagnosis when compared with individuals with Type 2 diabetes [6]. The gene discussed is INS; the disease is type 2 diabetes mellitus.